{
    "symbol": "ACAD",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-02 22:13:07",
    "content": "  Joining me on the call today from ACADIA are Stephen Davis, our Chief Executive Officer, who will provide an overview of our third quarter performance and a review of our business; Brendan Teehan, our Chief Operating Officer, Head of Commercial, will provide updates on our commercial performance; and Kathy Bishop, our Chief Scientific Officer and Head of will provide an overview of tripinetide; Dr. Srdjan Stankovic, our President, will then discuss our pipeline progress, Mark Schneider, our Chief Financial Officer, will discuss our financial results and guidance before turning it back to Steve for final remarks and opening the call up for your questions."
}